{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:45:50Z","timestamp":1760132750453,"version":"3.40.3"},"publisher-location":"Cham","reference-count":55,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031803956"},{"type":"electronic","value":"9783031803963"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-80396-3_5","type":"book-chapter","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:59:37Z","timestamp":1742356777000},"page":"129-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medullary Thyroid Carcinoma: Imaging"],"prefix":"10.1007","author":[{"given":"Stefan","family":"Delorme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Raue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Beuthien-Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00268-008-9588-7","volume":"32","author":"JE Ahn","year":"2008","unstructured":"Ahn JE, Lee JH, Yi JS et al (2008) Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg 32:1552\u20131558","journal-title":"World J Surg"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/thy.2023.0008","volume":"33","author":"S Ballal","year":"2023","unstructured":"Ballal S, Yadav MP, Roesch F et al (2023) Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC positron emission tomography\/computed tomography imaging for the follow-up surveillance of patients with medullary thyroid cancer. Thyroid 33:974\u2013982","journal-title":"Thyroid"},{"key":"5_CR3","first-page":"912","volume":"37","author":"E Baudin","year":"1996","unstructured":"Baudin E, Lumbroso J, Schlumberger M et al (1996) Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med 37:912\u2013916","journal-title":"J Nucl Med"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/snuc.2002.31028","volume":"32","author":"TM Behr","year":"2002","unstructured":"Behr TM, B\u00e9h\u00e9 MP (2002) Cholecystokinin-B\/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin Nucl Med 32:97\u2013109","journal-title":"Semin Nucl Med"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2436::AID-CNCR16>3.0.CO;2-D","volume":"80","author":"TM Behr","year":"1997","unstructured":"Behr TM, Gratz S, Markus PM et al (1997) Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors? Cancer 80:2436\u20132457","journal-title":"Cancer"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1148\/radiol.2371042060","volume":"237","author":"S Bipat","year":"2005","unstructured":"Bipat S, van Leeuwen MS, Comans EF et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis\u2014meta-analysis. Radiology 237:123\u2013131","journal-title":"Radiology"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1245\/s10434-018-6829-3","volume":"25","author":"L Brammen","year":"2018","unstructured":"Brammen L, Niederle MB, Riss P et al (2018) Medullary thyroid carcinoma: do ultrasonography and F-DOPA-PET-CT influence the initial surgical strategy? Ann Surg Oncol 25:3919\u20133927","journal-title":"Ann Surg Oncol"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"9998","DOI":"10.3748\/wjg.v20.i29.9998","volume":"20","author":"V Cantisani","year":"2014","unstructured":"Cantisani V, Grazhdani H, Fioravanti C et al (2014) Liver metastases: contrast-enhanced ultrasound compared with computed tomography and magnetic resonance. World J Gastroenterol 20:9998\u201310007","journal-title":"World J Gastroenterol"},{"key":"5_CR9","first-page":"430","volume":"52","author":"MR Castellani","year":"2008","unstructured":"Castellani MR, Seregni E, Maccauro M et al (2008) MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role? Q J Nucl Med Mol Imaging 52:430\u2013440","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1754-9485.2012.02344.x","volume":"56","author":"X Cheng","year":"2012","unstructured":"Cheng X, Bao L, Xu Z et al (2012) 18F-FDG-PET and 18F-FDG-PET\/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis. J Med Imaging Radiat Oncol 56:136\u2013142","journal-title":"J Med Imaging Radiat Oncol"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1258\/ar.2010.100247","volume":"52","author":"N Choi","year":"2011","unstructured":"Choi N, Moon WJ, Lee JH et al (2011) Ultrasonographic findings of medullary thyroid cancer: differences according to tumor size and correlation with fine needle aspiration results. Acta Radiol 52:312\u2013316","journal-title":"Acta Radiol"},{"key":"5_CR12","first-page":"33","volume":"29","author":"SE Clarke","year":"1988","unstructured":"Clarke SE, Lazarus CR, Wraight P et al (1988) Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP\u2014an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 29:33\u201338","journal-title":"J Nucl Med"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1245\/ASO.2004.10.015","volume":"11","author":"JW de Groot","year":"2004","unstructured":"de Groot JW, Links TP, Jager PL et al (2004) Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 11:786\u2013794","journal-title":"Ann Surg Oncol"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/1066896906299118","volume":"15","author":"MP Foschini","year":"2007","unstructured":"Foschini MP, Ragazzi M, Parmeggiani AL et al (2007) Comparison between echo-color Doppler sonography features and angioarchitecture of thyroid nodules. Int J Surg Pathol 15:135\u2013142","journal-title":"Int J Surg Pathol"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2265.1995.tb02595.x","volume":"42","author":"K Frank-Raue","year":"1995","unstructured":"Frank-Raue K, Bihl H, Dorr U et al (1995) Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin Endocrinol 42:31\u201337","journal-title":"Clin Endocrinol"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40644-023-00583-6","volume":"23","author":"L Gao","year":"2023","unstructured":"Gao L, Ma L, Li X et al (2023) Using preoperative ultrasound vascularity characteristics to estimate medullary thyroid cancer. Cancer Imaging 23:64","journal-title":"Cancer Imaging"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00259-019-04458-6","volume":"47","author":"L Giovanella","year":"2020","unstructured":"Giovanella L, Treglia G, Iakovou I et al (2020) EANM practice guideline for PET\/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 47:61\u201377","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1210\/jc.2007-1211","volume":"92","author":"AL Giraudet","year":"2007","unstructured":"Giraudet AL, Vanel D, Leboulleux S et al (2007) Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 92:4185\u20134190","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jc.2002-021354","volume":"88","author":"L Gourgiotis","year":"2003","unstructured":"Gourgiotis L, Sarlis NJ, Reynolds JC et al (2003) Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 88:637\u2013641","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3390\/jcm9113507","volume":"9","author":"E Grossrubatscher","year":"2020","unstructured":"Grossrubatscher E, Fanciulli G, Pes L et al (2020) Advances in the management of medullary thyroid carcinoma: focus on peptide receptor radionuclide therapy. J Clin Med 9:3507","journal-title":"J Clin Med"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-14-0964","volume":"172","author":"C Guerin","year":"2015","unstructured":"Guerin C, Lowery A, Gabriel S et al (2015) Preoperative imaging for focused parathyroidectomy: making a good strategy even better. Eur J Endocrinol 172:519\u2013526","journal-title":"Eur J Endocrinol"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2967\/jnumed.123.266537","volume":"65","author":"T G\u00fcnther","year":"2024","unstructured":"G\u00fcnther T, Holzleitner N, Viering O et al (2024) Preclinical evaluation of minigastrin analogs and proof-of-concept [68Ga]Ga-DOTA-CCK-66 PET\/CT in 2 patients with medullary thyroid cancer. J Nucl Med 65:33\u201339","journal-title":"J Nucl Med"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s002590000404","volume":"28","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, Altehoefer C, Ghanem N et al (2001) 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 28:64\u201371","journal-title":"Eur J Nucl Med"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1196\/annals.1296.061","volume":"1018","author":"I Ilias","year":"2004","unstructured":"Ilias I, Pacak K (2004) Anatomical and functional imaging of metastatic pheochromocytoma. Ann N Y Acad Sci 1018:495\u2013504","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1677\/ERC-07-0045","volume":"14","author":"I Ilias","year":"2007","unstructured":"Ilias I, Sahdev A, Reznek RH et al (2007) The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14:587\u2013599","journal-title":"Endocr Relat Cancer"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s00330-008-1073-z","volume":"18","author":"AE Jacques","year":"2008","unstructured":"Jacques AE, Sahdev A, Sandrasagara M et al (2008) Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 18:2885\u20132892","journal-title":"Eur Radiol"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3348\/kjr.2009.10.2.101","volume":"10","author":"SH Kim","year":"2009","unstructured":"Kim SH, Kim BS, Jung SL et al (2009) Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Korean J Radiol 10:101\u2013105","journal-title":"Korean J Radiol"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2967\/jnumed.107.047720","volume":"49","author":"KP Koopmans","year":"2008","unstructured":"Koopmans KP, de Groot JW, Plukker JT et al (2008) 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation. J Nucl Med 49:524\u2013531","journal-title":"J Nucl Med"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T et al (2019) 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med 60:801\u2013805","journal-title":"J Nucl Med"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/thy.2006.0338","volume":"17","author":"T Kudo","year":"2007","unstructured":"Kudo T, Miyauchi A, Ito Y et al (2007) Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17:635\u2013638","journal-title":"Thyroid"},{"key":"5_CR31","first-page":"99","volume":"77","author":"J Leclere","year":"1996","unstructured":"Leclere J, Sidibe S, Lassau N et al (1996) Ultrasonographic aspects of hepatic metastases of thyroid medullary cancers. J Radiol 77:99\u2013103","journal-title":"J Radiol"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"bvad145","DOI":"10.1210\/jendso\/bvad145","volume":"8","author":"J Li","year":"2023","unstructured":"Li J, Dou J, Li H et al (2023a) Contrast enhancement ultrasound improves diagnostic accuracy for thyroid nodules: a prospective multicenter study. J Endocr Soc 8:bvad145","journal-title":"J Endocr Soc"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/MNM.0000000000001773","volume":"44","author":"P Li","year":"2023","unstructured":"Li P, Zhang Y, Xu T et al (2023b) Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET\/CT: a network meta-analysis and systematic review. Nucl Med Commun 44:1114\u20131125","journal-title":"Nucl Med Commun"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/thy.2009.0342","volume":"20","author":"M Luster","year":"2010","unstructured":"Luster M, Karges W, Zeich K et al (2010) Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography\/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid 20:527\u2013533","journal-title":"Thyroid"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H (2010) Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655\u20132663","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1210\/jc.2012-3192","volume":"98","author":"A Machens","year":"2013","unstructured":"Machens A, Lorenz K, Dralle H (2013) Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J Clin Endocrinol Metab 98:E336\u2013E345","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2004-1500","volume":"90","author":"E Miralli\u00e9","year":"2005","unstructured":"Miralli\u00e9 E, Vuillez JP, Bardet S et al (2005) High frequency of bone\/bone marrow involvement in advanced medullary thyroid cancer. J Clin Endocrinol Metab 90:779\u2013788","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2967\/jnumed.106.036681","volume":"48","author":"SC Ong","year":"2007","unstructured":"Ong SC, Sch\u00f6der H, Patel SG et al (2007) Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 48:501\u2013507","journal-title":"J Nucl Med"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1210\/jc.2007-0938","volume":"92","author":"A Oudoux","year":"2007","unstructured":"Oudoux A, Salaun PY, Bournaud C et al (2007) Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy. J Clin Endocrinol Metab 92:4590\u20134597","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","volume":"142","author":"FJ Quayle","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R et al (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142:800\u2013805; discussion 805.e1","journal-title":"Surgery"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00259-018-4045-9","volume":"45","author":"S Rasul","year":"2018","unstructured":"Rasul S, Hartenbach S, Rebhan K et al (2018) [18F]DOPA PET\/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery. Eur J Nucl Med Mol Imaging 45:2159\u20132169","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<644::AID-IJC9>3.0.CO;2-U","volume":"67","author":"JC Reubi","year":"1996","unstructured":"Reubi JC, Waser B (1996) Unexpected high incidence of cholecystokinin-B\/gastrin receptors in human medullary thyroid carcinomas. Int J Cancer 67:644\u2013647","journal-title":"Int J Cancer"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ejso.2007.08.005","volume":"34","author":"D Rubello","year":"2008","unstructured":"Rubello D, Rampin L, Nanni C et al (2008) The role of 18F-FDG PET\/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study. Eur J Surg Oncol 34:581\u2013586","journal-title":"Eur J Surg Oncol"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/cen.12566","volume":"81","author":"P Santhanam","year":"2014","unstructured":"Santhanam P, Ta\u00efeb D (2014) Role of (18)F-FDOPA PET\/CT imaging in endocrinology. Clin Endocrinol 81:789\u2013798","journal-title":"Clin Endocrinol"},{"issue":"3","key":"5_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1210\/endrev\/bnae001","volume":"45","author":"HJLM Timmers","year":"2024","unstructured":"Timmers HJLM, Ta\u00efeb D, Pacak K et al (2024) Imaging of pheochromocytomas and paragangliomas. Endocr Rev 45(3):414\u2013434. https:\/\/doi.org\/10.1210\/endrev\/bnae001","journal-title":"Endocr Rev"},{"issue":"4","key":"5_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00259-011-2031-6","volume":"39","author":"G Treglia","year":"2012","unstructured":"Treglia G, Castaldi P, Villani MF et al (2012) Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET\/CT in patients with recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 39(4):569\u2013580. https:\/\/doi.org\/10.1007\/s00259-011-2031-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.semnuclmed.2023.01.003","volume":"53","author":"G Treglia","year":"2023","unstructured":"Treglia G, Rufini V, Piccardo A et al (2023) Update on management of medullary thyroid carcinoma: focus on nuclear medicine. Semin Nucl Med 53:481\u2013489","journal-title":"Semin Nucl Med"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1089\/thy.2008.0082","volume":"18","author":"V Triggiani","year":"2008","unstructured":"Triggiani V, Guastamacchia E, Licchelli B et al (2008) Microcalcifications and psammoma bodies in thyroid tumors. Thyroid 18:1017\u20131018","journal-title":"Thyroid"},{"key":"5_CR49","first-page":"327","volume":"35","author":"L Troncone","year":"1991","unstructured":"Troncone L, Rufini V, Maussier ML et al (1991) The role of [131I]metaiodobenzylguanidine in the treatment of medullary thyroid carcinoma: results in five cases. J Nucl Biol Med 35:327\u2013331","journal-title":"J Nucl Biol Med"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2967\/jnumed.112.105940","volume":"53","author":"HH Verbeek","year":"2012","unstructured":"Verbeek HH, Plukker JT, Koopmans KP et al (2012) Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma. J Nucl Med 53:1863\u20131871","journal-title":"J Nucl Med"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2967\/jnumed.123.266380","volume":"65","author":"O Viering","year":"2024","unstructured":"Viering O, G\u00fcnther T, Holzleitner N et al (2024) CCK2 receptor-targeted PET\/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66. J Nucl Med 65:493\u2013494","journal-title":"J Nucl Med"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"Wells SA, Asa SL, Dralle H et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567\u2013610","journal-title":"Thyroid"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2967\/jnumed.117.199778","volume":"59","author":"RA Werner","year":"2018","unstructured":"Werner RA, Schmid JS, Higuchi T et al (2018) Predictive value of 18F-FDG PET in patients with advanced medullary thyroid carcinoma treated with vandetanib. J Nucl Med 59:756\u2013761","journal-title":"J Nucl Med"},{"key":"5_CR54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5603\/EP.2014.0043","volume":"65","author":"K Wolinski","year":"2014","unstructured":"Wolinski K, Rewaj-Losyk M, Ruchala M (2014) Sonographic features of medullary thyroid carcinomas\u2014a systematic review and meta-analysis. Endokrynol Pol 65:314\u2013318","journal-title":"Endokrynol Pol"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/thy.2009.0045","volume":"20","author":"B Zhang","year":"2010","unstructured":"Zhang B, Jiang YX, Liu JB et al (2010) Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules. Thyroid 20:51\u201357","journal-title":"Thyroid"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-80396-3_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:32:11Z","timestamp":1742358731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-80396-3_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031803956","9783031803963"],"references-count":55,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-80396-3_5","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"type":"print","value":"0080-0015"},{"type":"electronic","value":"2197-6767"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"20 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}